Laboratory Value Monitoring
Laboratory Value Monitoring is a systematic clinical process involving the periodic measurement and evaluation of specific biochemical or hematological markers in patient samples to detect or prevent adverse drug events through early identification of drug-induced physiological abnormalities.
29
Publications
1.5K
Citations
245
Authors
110
Institutions
Publications per year
2017–2026
5
29
FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma
Virginia E. Kwitkowski, Tatiana M. Prowell, Amna Ibrahim et al. · The Oncologist · 2010 · 249 citations · Full text
Medicine, Oncology, Pharmacotherapy +16
Subcutaneous Use of a Fast-Acting Insulin Analog
Thaís Della Manna, Leandra Steinmetz, Paula R. Campos et al. · Diabetes Care · 2005 · 108 citations · Full text
Marsha A. Raebel, David L. McClure, Steven R. Simon et al. · Pharmacoepidemiology and Drug Safety · 2006 · 88 citations
Pharmacy, Nephrology, Pharmacology +17
1–5 of 29
245
2
h-index
2
h-index
1
h-index
1
h-index
1
h-index
1–5 of 245
110
University of Pittsburgh
Pittsburgh, United States
3 h-index
9 publications
262 citations
University of Michigan
Ann Arbor, United States
2 h-index
3 publications
101 citations
Harvard University
Cambridge, United States
2 h-index
19 publications
568 citations
University of Pennsylvania
Philadelphia, United States
2 h-index
9 publications
491 citations

University Medical Center Freiburg
Freiburg im Breisgau, Germany
1 h-index
3 publications
57 citations
University of Pavia
Pavia, Italy
1 h-index
2 publications
38 citations
Istituti Clinici Scientifici Maugeri
Pavia, Italy
1 h-index
4 publications
76 citations
Azienda di Servizi alla Persona di Pavia (Italy)
Pavia, Italy
1 h-index
2 publications
38 citations
1–8 of 110
4 publications · 150 citations
4
h-index
Repository · 2 publications · 68 citations
2
h-index
2 publications · 98 citations
2
h-index
AJHP · 2 publications · 51 citations
2
h-index
1 publications · 249 citations
1
h-index
1–5